Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier subjects
- 1 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 2 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 3 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 4 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 5 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 6 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 7 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 8 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
- 9 Medical Private hospital of Danga, Cocody, Abidjan, Cote d’Ivoire
- 10 Department of General Medicine and Hepato-Gastroenterology, Teaching Hospital of Yopougon, Abidjan, Cote d’Ivoire
Abstract
Aims of the Study: 1) Determine the Prevalence of Hepatitis B virus (HBV) infection in children (contact subjects) of chronic Hepatitis B surface antigen (HBsAg) carrier subjects (index subjects); 2) Search for factors associated with HBV infection in these children. Patients and Methods: Retrospective-crosssectional study (January 5th, 2006 through December 31st, 2012). Studied parameters: biological and clinical characteristics of index subjects; Prevalence of HBsAg and Hepatitis B core antibody (HBcAb) in their children. Search for the HBV infection associated factors in the children (univariate analyses through Chi-square or Fisher’s exact test; multivariate analysis through a backward logistic regression). Results: Our 44 subjects’ median age was 43.1 ± 7.49 years and 88.6% of them lived with a spouse. Average number of children per index subjects was 2.3 ± 1.1. Our 92 children’s median age was 9.3 ± 4.55 (ranging from 1 to 15 years), and 43 (44.8%) were vaccinated against HBV. HBV infection prevalence was 24% (23/96 of which, 4 were HBsAg positive and 19 HBcAb positive subjects without HBsAg). Independent factors associated with HBV infection in children of index subjects were HBV DNA for index subjects >2000 IU/ml (OR = 11.5; p = 0.001), existence of HBV in two parents (OR = 7.9; p = 0.03) and absence of HBV vaccination in the children (OR = 30.9; p = 0.003). Conclusion: Immunization coverage for children of index subjects was insufficient, especially before the introduction of HBV vaccine into the enlarged vaccination program. Outside vertical transmission, those children were more exposed to HBV intrafamilial transmission risk when they were not immunized against HBV, when both parents were infected and when HBV viremia in index subjects was higher than 2000 IU/ml.
- Wright, T.L. and Lau, J.Y.N. (1993) Clinical aspects of hepatitis B virus infection. Lancet, 342, 1340-1344. doi:10.1016/0140-6736(93)92250-W
- Murray, C.J. and Lopez, A.D. (1997) Mortality by cause for eight regions of the world: Global burden of disease study. Lancet, 349, 1269-1276. doi:10.1016/S0140-6736(96)07493-4
- Lai, C.L., Ratziu, V., Yeun, M.F. and Poynard, T. (2003) Viral hepatitis B. Lancet, 362, 2089-2094. doi:10.1016/S0140-6736(03)15108-2
- Goldstein, S.T., Zhou, F., Hadler, S.C., et al. (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. International Journal of Epidemiology, 34, 1329-1339. doi:10.1093/ije/dyi206
- Hoffmann, C.J. and Thio, C.L. (2007) Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infectious Diseases, 7, 402-409. doi:10.1016/S1473-3099(07)70135-4
- Shi, Y.H. and Shi, C.H. (2009) Molecular characteristics and stages of chronic hepatitis B virus infection. World Journal of Gastroenterology, 15, 3099-3105. doi:10.3748/wjg.15.3099
- Hadziyannis, S.J. (2011) Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. Journal of Hepatology, 55, 183-191. doi:10.1016/j.jhep.2010.12.030
- Lohouès-Kouacou, M.J., Touré, M., Hillah. J., et al. (2009) Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination. Sante, 8, 401-404.
- Sangaré, L., Sombié, R., Combasséré, A.W., et al.(2009) Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bulletin de la Société de Pathologie Exotique, 102, 226-229.
- Martinson, F.E., Weigle, K.A., Royce, R.A., et al. (1998) Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. American Journal of Epidemiology, 147, 478-487. doi:10.1093/oxfordjournals.aje.a009474
- Candotti, D., Danso, K. and Allain, J.P. (2007) Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. Journal of General Virology, 88, 2686-2695. doi:10.1099/vir.0.83102-0
- Wiseman, E., Fraser, M.A., Holden, S., et al. (2009) Perinatal transmission of hepatitis B virus: An Australian experience. Medical Journal of Australia, 190, 489-492.
- Xu, W.M., Cui, Y.T., Wang, L., et al. (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, randomized, double-blind, placebo-controlled study. Journal of Viral Hepatitis, 16, 94-103. doi:10.1111/j.1365-2893.2008.01056.x